Cargando…

Hearing improvement in a variant Muckle–Wells syndrome case in response to IL-1 receptor antagonism

Detalles Bibliográficos
Autores principales:	Rynne, M, Maclean, C, McDermott, MF, Emery, P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834095/ http://dx.doi.org/10.1186/ar1617

Ejemplares similares

IL-1 inhibition in Muckle-Wells-Syndrome: withdrawal resulting in rapid deterioration of hearing loss
por: Hansmann, S, et al.
Publicado: (2015)

Hypofertility in Muckle Wells syndrome and treatment with IL-1 targeting drugs
por: Meinzer, Ulrich, et al.
Publicado: (2011)

A large family having Muckle Wells Syndrome
por: Kilic, SS, et al.
Publicado: (2015)

Somatic NLRP3 mosaicism in Muckle-Wells syndrome
por: Gonzalez-Roca, E, et al.
Publicado: (2015)

Delayed diagnosis of Muckle-Wells syndrome – analysis of influencing factors
por: Kuemmerle-Deschner, Jasmin B, et al.
Publicado: (2012)

PReS-FINAL-2336: Induction of MDSCS in Muckle-Wells syndrome
por: Rieber, N, et al.
Publicado: (2013)

Anti-IL1ß-monoclonal antibody in a patient with Muckle-Wells Syndrome and renal transplantation - five years experience
por: Kortus-Götze, B, et al.
Publicado: (2015)

Familial case of Muckle-Wells syndrome in the Russian population: a long way to the diagnosis
por: Salugina, Svetlana O, et al.
Publicado: (2014)

Early detection of sensorineural hearing loss in Muckle-Wells-syndrome
por: Kuemmerle-Deschner, Jasmin B., et al.
Publicado: (2015)

Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
por: Salugina, SO, et al.
Publicado: (2011)

Muckle–Wells syndrome: clinical perspectives
por: Tran, Tu-Anh
Publicado: (2017)

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)
por: Wittkowski, H, et al.
Publicado: (2008)

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens
por: Kuemmerle-Deschner, Jasmin B, et al.
Publicado: (2013)

PW02-042 - Induction of MDSC in Muckle-Wells syndrome
por: Rieber, N, et al.
Publicado: (2013)

P02-028 - Muckle-Wells syndrome and renal transplantation
por: Kortus-Götze, B, et al.
Publicado: (2013)

Successful renal transplantation in Muckle–Wells syndrome treated with anti-IL-1β-monoclonal antibody
por: Kortus-Götze, Birgit, et al.
Publicado: (2011)

Prostaglandins and prostaglandin receptor antagonism in migraine
por: Antonova, M
Publicado: (2013)

Muckle–Wells syndrome in an Indian family associated with NLRP3 mutation
por: Abdulla, MC, et al.
Publicado: (2015)

Intracellular IL-1 receptor antagonist (icIL-1Ra1) does not antagonize growth inhibitory effects of pre-IL-1α in SaOS-2 cells
por: Palmer, G, et al.
Publicado: (2005)

Erratum: Muckle–Wells syndrome in an Indian family associated with NLRP3 mutation
Publicado: (2020)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
por: Kaufman, Howard L, et al.
Publicado: (2014)

Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature
por: Liu, Jia, et al.
Publicado: (2023)

Muckle-Wells Syndrome Across Four Generations in One Czech Family: Natural Course of the Disease
por: Fingerhutová, Šárka, et al.
Publicado: (2019)

Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2
por: Wong, Michael KK, et al.
Publicado: (2015)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

P02.124. A pilot randomized controlled trial of yoga for prediabetes
por: McDermott, K
Publicado: (2012)

Cannabinoid 2 receptor antagonism reverses central nervous system injury-induced immune deficiency syndrome
por: Burkovskiy, IB, et al.
Publicado: (2015)

High dose interleukin-2 registry, PROCLAIM™; higher center-specific IL-2 dose density correlates with higher response rates
por: Wong, Michael K, et al.
Publicado: (2013)

Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra: a case report and review of the literature
por: Marchica, Cinzia, et al.
Publicado: (2018)

A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome
por: Hu, Jian, et al.
Publicado: (2017)

The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
por: Leinonen, Mika, et al.
Publicado: (2014)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2)
por: Clark, Joseph I, et al.
Publicado: (2015)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle–Wells syndrome
por: Kaneko, Naoe, et al.
Publicado: (2020)

Improvement of T-cell function in rheumatoid arthritis (RA) patients in clinical remission is associated with the recovery of IL-7 expression and depends on a familial history of RA
por: Ponchel, F, et al.
Publicado: (2005)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

Case report: The altered rate of monocytic cell death in a patient of Muckle-Wells syndrome with atypical clinical course
por: Murakawa, Saori, et al.
Publicado: (2023)

Calcium antagonism effects on cerebral blood flow in rats with acute hydrocephalus
por: Shulyakov, Alexander Victor, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hhfc9eekakl931qp3cnclhqaa5